1.Frank AL, et al. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clinical Infectious Diseases 1999; 29: 935–936.
2.Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus – Minnesota and North Dakota, 1997–1999. Morbidity Mortality Weekly Report 1999; 48: 707–710.
3.Adcock PM, et al. Methicillin-resistant Staphylococcus aureus in two child care centers. Journal of Infectious Diseases 1998; 178: 577–580.
4.Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerging Infectious Diseases 2002; 8: 602–607.
5.Turnidge JD, Bell JM. Methicillin-resistant Staphylococcus aureus evolution in Australia over 35 years. Microbial Drug Resistance 2000; 6: 223–229.
6.Kaplan SL, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clinical Infectious Diseases 2005; 40: 1785–1791.
7.Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 2006; 355: 666–674.
8.Borer AA, et al. Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Emerging Infectious Diseases 2002; 8: 966–970.
9.Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities – Georgia, California, and Texas, 2001–2003. Morbidity Mortality Weekly Report 2003; 52: 992–996.
10.Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants – Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. Morbidity Mortality Weekly Report 2003; 52: 793–795.
11.LaMar JE, et al. Sentinel cases of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship. Military Medicine 2003; 168: 135–138.
12.Saiman L, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clinical Infectious Diseases 2003; 37: 1313–1319.
13.Baggett HC, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infection Control & Hospital Epidemiology 2003; 24: 397–402.
14.Baggett HC, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antimicrobial use and cytotoxin Panton-Valentine Leukocidin during a furunculosis outbreak in rural Alaska. Journal of Infectious Diseases 2004; 189: 1565–1573.
15.Kazakova SV, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. New England Journal of Medicine 2005; 352: 468–475.
16.Turabelidze G, et al. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerging Infectious Diseases 2006; 12: 422–427.
17.Naimi TS, et al. Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. Journal of the American Medical Association 2003; 290: 2976–2984.
18.National Committee for Clinical Laboratory Standards. Methods for dilution Antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, Sixth Edition. NCCLS document M7-A6 ed, vol. 6. Wayne, PA: NCCLS, 2003.
19.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Fourteenth Informational Supplement. NCCLS document M100-S14 ed, vol. 14. Wayne, PA: NCCLS, 2004.
20.Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233–2239.
21.McDougal LK, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. Journal of Clinical Microbiology 2003; 41: 5113–5120.
22.Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128–1132.
23.Monday SR, Bohach GA. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. Journal of Clinical Microbiology 1999; 37: 3411–3414.
24.Chiang YC, et al. PCR primers for the detection of staphylococcal enterotoxins K, L, and M and survey of staphylococcal enterotoxin types in Staphylococcus aureus isolates from food poisoning cases in Taiwan. Journal of Food Protection 2006; 69: 1072–1079.
25.Chiang YC, et al. PCR detection of staphylococcal enterotoxins (SEs) N, O, P, Q, R, U, and survey of SE types in Staphylococcus aureus isolates from food- poisoning cases in Taiwan. International Journal of Food Microbiology 2008; 121: 66–73.
26.Miller LG, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clinical Infectious Diseases 2007; 44: 471–482.
27.David MZ, et al. Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates. Journal of Clinical Microbiology 2008; 46: 3222–3227.
28.Hota B, et al. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital. Archives Internal Medicine 2007; 167: 1026–1033.
29.Sattler CA, Mason EO, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatric Infectious Diseases Journal 2002; 21: 910–916.
30.Skiest DJ, et al. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. Journal of Infection 2007; 54: 427–434.
31.Davis SL, et al. Epidemiology and outcomes of community-associated Staphylococcus aureus infection. Journal of Clinical Microbiology 2007; 45: 1705–1711.
32.Schneider-Lindner V, et al. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerging Infectious Diseases 2007; 13: 994–1000.
33.Nuorti JP, et al. Cigarette smoking and invasive pneumococcal disease. New England Journal of Medicine 2000; 342: 681–689.
34.Seybold J, et al. Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries. Pediatrics 2008; 122: 1039–1046.
35.Bogaert D, et al. Colonization by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004; 363; 1871–1872.
36.Melles DC, et al. Nasopharyngeal co-colonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. Microbiology 2007; 153: 686–692.
37.Issartel B, et al. Frequent carriage of Panton-Valentine leukocidin genes by Staphylococcus aureus isolates from surgically drained abscesses. Journal of Clinical Microbiology 2005; 43: 3203–3207.
38.Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128–1132.
39.Li M, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Acadaemy of Sciences USA. 2009; 106: 5883–5888.
40.David MZ, et al. What is community-associated methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 2008; 197: 1217–1219.
41.Schlievert PM, et al. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clinical Infectious Diseases 2008; 46: 1562–1567.
42.Fridkin SK, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 1436–1444.
43.Buckingham SC, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee children's hospital. Pediatric Infectious Diseases Journal 2004; 23: 619–624.
44.Como-Sabetti K, et al. Community-associated methicillin-resistant Staphylococcus aureus: Trends in case and isolate characteristics from 6 years of prospective surveillance. Public Health Report 2009; 124: 427–435.
45.Diep BA, et al. Emergence of multidrug-resistance, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Annals of Internal Medicine 2008; 148: 249–257.